As it is reported that several TP53 point mutations are related to the effect of cigarette exposure in lung cancers [33–35] and squamous cell carcinomas of the head and neck [36], which is similar to our finding in patients with ESCC, a group that the percentage of smokers have higher TP53 mutations. This evidence concerns the gene TP53 and lung carcinoma.